Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · September 17, 2024

Continuation vs Interruption of Oral Anticoagulation During TAVI

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Continuation versus Interruption of Oral Anticoagulation during TAVI
N. Engl. J. Med 2024 Aug 31;[EPub Ahead of Print], DJ van Ginkel, WL Bor, HM Aarts, C Dubois, O De Backer, MJP Rooijakkers, L Rosseel, L Veenstra, F van der Kley, KH van Bergeijk, NM Van Mieghem, P Agostoni, M Voskuil, CE Schotborgh, AJJ IJsselmuiden, JAS Van Der Heyden, RS Hermanides, E Barbato, D Mylotte, E Fabris, P Frambach, K Dujardin, B Ferdinande, J Peper, BJWM Rensing, L Timmers, MJ Swaans, J Brouwer, VJ Nijenhuis, DC Overduin, T Adriaenssens, Y Kobari, PA Vriesendorp, JM Montero-Cabezas, H El Jattari, J Halim, BJL Van den Branden, R Leonora, M Vanderheyden, M Lauterbach, JJ Wykrzykowska, AWJ van 't Hof, N van Royen, JGP Tijssen, R Delewi, JM Ten Berg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading